MS
Insider
Mark C. Schneyer
EVP, CHIEF FINANCIAL OFFICERMark C. Schneyer (EVP, CHIEF FINANCIAL OFFICER) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in ACADIA Pharmaceuticals Inc. (ACAD). The largest single filing was $587K of ACAD (20,141 sh across 3 lots, as filed), executed Aug 5.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
2
0 buys · 2 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$830K
shares × price, as filed
Last traded
Aug 6
Filed Aug 7
Median ADV $49.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.6M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
2 filings
Sector per market data · by filing · past 12 months
Most traded names
ACADRecent filings
ACADSALE
ACADIA Pharmaceuticals Inc.
View filing →
$587K20,141 sh across 3 lots
Exec Aug 5
Filed Aug 7 · 6:00 PM ET ACADSALE ACADIA Pharmaceuticals Inc. View filing → $243K
10,262 sh × $23.69
Exec Nov 18 2025
Filed Nov 19 2025 · 5:30 PM ET ACADSALE ACADIA Pharmaceuticals Inc. View filing → $554K
22,000 sh × $25.18
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET ACADSALE ACADIA Pharmaceuticals Inc. View filing → $172K
10,259 sh × $16.81
Exec Nov 19 2024
Filed Nov 19 2024 · 5:30 PM ET